The stock has a 36-month beta value of 2.36. Opinions on the stock are mixed, with 1 analysts rating it as a “buy,” 0 as “overweight,” 2 as “hold,” and 0 as “sell.”
The public float for KOD is 48.63M, and at present, short sellers hold a 4.20% of that float. On July 10, 2025, the average trading volume of KOD was 388.07K shares.
KOD) stock’s latest price update
Kodiak Sciences Inc (NASDAQ: KOD)’s stock price has soared by 13.85% in relation to previous closing price of $3.9. Nevertheless, the company has seen a gain of 18.09% in its stock price over the last five trading days. prnewswire.com reported 2025-06-25 that PALO ALTO, Calif., June 25, 2025 /PRNewswire/ — Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat a broad spectrum of retinal diseases, announced today that management along with key opinion leaders will present KSI-101 highlights at the 2025 Congress of the International Ocular Inflammation Society (IOIS) in Rio de Janeiro, Brazil on Friday, June 27, 2025.
KOD’s Market Performance
Kodiak Sciences Inc (KOD) has seen a 18.09% rise in stock performance for the week, with a 5.21% gain in the past month and a 103.67% surge in the past quarter. The volatility ratio for the week is 7.89%, and the volatility levels for the past 30 days are at 7.45% for KOD. The simple moving average for the past 20 days is 16.87% for KOD’s stock, with a -7.32% simple moving average for the past 200 days.
Analysts’ Opinion of KOD
Many brokerage firms have already submitted their reports for KOD stocks, with Jefferies repeating the rating for KOD by listing it as a “Buy.” The predicted price for KOD in the upcoming period, according to Jefferies is $20 based on the research report published on December 09, 2024 of the previous year 2024.
H.C. Wainwright, on the other hand, stated in their research note that they expect to see KOD reach a price target of $3. The rating they have provided for KOD stocks is “Neutral” according to the report published on September 05th, 2024.
Goldman gave a rating of “Sell” to KOD, setting the target price at $2 in the report published on December 11th of the previous year.
KOD Trading at 14.77% from the 50-Day Moving Average
After a stumble in the market that brought KOD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -61.72% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at KOD starting from BORGESON JOHN A., who sale 723 shares at the price of $3.65 back on Jun 17 ’25. After this action, BORGESON JOHN A. now owns 183,316 shares of Kodiak Sciences Inc, valued at $2,640 using the latest closing price.
Stock Fundamentals for KOD
The total capital return value is set at -0.75. Equity return is now at value -108.92, with -52.04 for asset returns.
Based on Kodiak Sciences Inc (KOD), the company’s capital structure generated 0.38 points at debt to capital in total, while cash flow to debt ratio is standing at -1.58.
Currently, EBITDA for the company is -149.5 million with net debt to EBITDA at 0.41. The liquidity ratio also appears to be rather interesting for investors as it stands at 4.62.
Conclusion
To sum up, Kodiak Sciences Inc (KOD) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
